Szilard Kiss, MD
Retina Specialist · New York, NYNPI 1023076593
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $130,894 of the $194,739 with a category attached, or 67.2%. 13 manufacturers reported payments, led by Optos PLC at 54.8% of the total. Among retina specialist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $2596.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optos PLC$107K
- Regeneron Healthcare Solutions, Inc.$37K
- Regeneron$9K
- Genentech, Inc.$8K
- Novartis$8K
- Apellis Pharmaceuticals, Inc.$8K
- plus $19K from 7 others
Across 2 payments — averaging $13,584 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$27K
What the payments were for
- Consulting fees$130,89467%
- Speaking & faculty fees$24,27012%
- Travel & lodging$38,45220%
- Food & beverage$1,0951%
- Entertainment$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optos PLC | 16 | $106,787 |
| Regeneron Healthcare Solutions, Inc. | 28 | $36,549 |
| Regeneron | 6 | $8,511 |
| Genentech, Inc. | 4 | $7,989 |
| Novartis | 2 | $7,925 |
| Apellis Pharmaceuticals, Inc. | 5 | $7,613 |
| F. Hoffmann-la Roche AG | 1 | $5,565 |
| Alcon | 4 | $5,140 |
| Harrow Eye, LLC | 2 | $2,947 |
| Genentech USA, Inc. | 3 | $2,408 |
| Spark Therapeutics, Inc. | 1 | $2,205 |
| Optos, Inc. | 2 | $1,028 |
| Bausch & Lomb Americas Inc. | 1 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$194,739 in reported general payments places this provider in the 95th percentile of 99 retina specialist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 12 | $8,630 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in New York
- Donald D'amicoNew York$109K
- Gareth LemaNew York$11K
- Megan Ridley LaneNew York$11K
- Carl WilkinsNew York$9K
- Gennady LandaNew York$7K
- Joseph TsengNew York$6K
- Ben CohenNew York$5K
- Alan SheymanNew York$4K
- Steven AgemyNew York$3K
- Louis AngiolettiNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.